author-photo

Aleander Nosov

2

Papers

2

Citations

Citation Trend

Filter By

Papers (2) Sort By

Journal Conference Others

Phase IIb trial of oral ModraDoc006/r as a tolerable and effective option in comparison with intravenous docetaxel in metastatic castration-resistant prostate cancer (mCRPC).

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
First-line use of cabazitaxel in chemotherapy-naive patients with metastatic castration-resistant prostate cancer (mCRPC): A three-arm study in comparison with docetaxel.

2012 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (2)